Phibro Animal Health (NASDAQ:PAHC) Hits New 1-Year High – Here’s What Happened

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) reached a new 52-week high during trading on Tuesday . The company traded as high as $26.77 and last traded at $26.62, with a volume of 271863 shares trading hands. The stock had previously closed at $25.54.

Analyst Ratings Changes

A number of research firms have recently commented on PAHC. BNP Paribas upgraded shares of Phibro Animal Health to a “hold” rating in a research report on Monday, June 16th. Morgan Stanley set a $26.00 price target on shares of Phibro Animal Health and gave the company an “equal weight” rating in a report on Wednesday, June 25th. BNP Paribas Exane raised Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 price objective for the company in a research note on Monday, June 16th. Finally, Wall Street Zen raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $21.80.

Phibro Animal Health Trading Up 4.2%

The firm has a market capitalization of $1.08 billion, a P/E ratio of 34.13, a price-to-earnings-growth ratio of 0.48 and a beta of 0.75. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67. The firm’s 50-day simple moving average is $22.99 and its 200-day simple moving average is $22.01.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. The business had revenue of $347.80 million during the quarter, compared to analyst estimates of $352.41 million. Analysts anticipate that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Wednesday, June 4th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.80%. The ex-dividend date of this dividend was Wednesday, June 4th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 61.54%.

Institutional Trading of Phibro Animal Health

A number of hedge funds have recently bought and sold shares of PAHC. Nuveen LLC bought a new stake in Phibro Animal Health in the first quarter valued at approximately $10,312,000. Invesco Ltd. raised its holdings in Phibro Animal Health by 92.3% in the first quarter. Invesco Ltd. now owns 387,739 shares of the company’s stock worth $8,282,000 after purchasing an additional 186,087 shares in the last quarter. Axecap Investments LLC bought a new position in shares of Phibro Animal Health in the 1st quarter worth about $3,696,000. Millennium Management LLC increased its stake in shares of Phibro Animal Health by 74.3% during the first quarter. Millennium Management LLC now owns 362,030 shares of the company’s stock valued at $7,733,000 after purchasing an additional 154,281 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its position in Phibro Animal Health by 56.7% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company’s stock valued at $6,325,000 after buying an additional 108,918 shares in the last quarter. Institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.